Cystic Fibrosis Research Fund

Analysis

Cystic Fibrosis Research Fund is a registered charity in United States, based in Ardmore, PA. It received its IRS tax-exemption ruling in July 2012, 14 years ago. Its declared purposes cover diseases, disorders and medical disciplines, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Cystic Fibrosis Research Fund reported income of $2.8m and spending of $2.1m, leaving 24% of income unspent that year. Across the 5 years on record, from December 2019 to December 2023, income grew from $2.1m to $2.8m (+34%), an average of +7.6% a year. The sharpest change came in the year to December 2023, when income rose by 56%. Over the whole period it spent 67% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Cystic Fibrosis Research Fund sits at the 75th percentile: it is larger than about 74% of them. Against every charity in United States with reported income it ranks in the 88th percentile, and in the 87th percentile within PA. Charities of a similar size with the same main cause include Strand-Kjorsvig Community Rest Home ($2.8m), Northeastern Vermont Regional Corp ($2.8m) and Willglo Services Inc ($2.8m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 94% of the total. Other salaries and wages came to $517k. At year end it held assets of $5.0m against liabilities of $170k, net assets of $4.8m. It reported 6 employees.